AMN Healthcare Services Inc

AMN remains in a Stage 2 uptrend, consolidating in a tight range above the rising 9/20/50 EMAs. The medium-term directional bias is bullish, as the consolidation structure reads as a bull flag signaling continuation. Short-term conditions are supportive: price is holding above the EMAs without overbought stress, and pullbacks into the 9/20 EMA zone offer a favorable entry. We will buy now on this pullback to engage in the ongoing uptrend.

• ↑Q2 revenue $673M and adjusted EPS $0.77 exceeded guidance; positive earnings revisions.
• ↑Nurse & Allied Solutions revenue $422M, up 11% YoY, shows strong segment demand.
• ↓Negative profitability metrics highlight operational inefficiency and low returns.